Integrated genomic and molecular characterization of cervical cancer

Abstract

Cervical cancer remains one of the leading causes of cancer-related deaths worldwide. Here we report the extensive molecular characterization of 228 primary cervical cancers, one of the largest comprehensive genomic studies of cervical cancer to date. We observed notable APOBEC mutagenesis patterns and identified SHKBP1, ERBB3, CASP8, HLA-A and TGFBR2 as novel significantly mutated genes in cervical cancer. We also discovered amplifications in immune targets CD274 (also known as PD-L1) and PDCD1LG2 (also known as PD-L2), and the BCAR4 long non-coding RNA, which has been associated with response to lapatinib. Integration of human papilloma virus (HPV) was observed in all HPV18-related samples and 76% of HPV16-related samples, and was associated with structural aberrations and increased target-gene expression. We identified a unique set of endometrial-like cervical cancers, comprised predominantly of HPV-negative tumours with relatively high frequencies of KRAS, ARID1A and PTEN mutations. Integrative clustering of 178 samples identified keratin-low squamous, keratin-high squamous and adenocarcinoma-rich subgroups. These molecular analyses reveal new potential therapeutic targets for cervical cancers. This paper describes molecular subtypes of cervical cancers, including squamous cell carcinoma and adenocarcinoma clusters defined by HPV status and molecular features, and distinct molecular pathways that are activated in cervical carcinomas caused by different somatic alterations and HPV types. Cervical cancer is one of the main causes of cancer-related deaths worldwide, and 95% of cases result from human papilloma virus (HPV) infection. The Cancer Genome Atlas Research Network now reports the genomic and molecular characterization of 228 primary cervical cancers. The authors identify significantly mutated genes and pathways that differ by cervical cancer subtype, and find that keratin-low squamous, keratin-high squamous and adenocarcinoma-rich clusters are marked by different HPV types and molecular features.

Cited by papers we hold 30

• Genomic characterization of small cell carcinomas of the uterine cervix · 2022
  Not checked
• Low Transforming Growth Factor-β Pathway Activity in Cervical Adenocarcinomas · 2022
  Not checked
• Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies · 2022
  Not checked
• Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data · 2021
  Not checked
• Cervical Carcinoma: Oncobiology and Biomarkers · 2021
  No notice
• Persistent Human Papillomavirus Infection · 2021
  No notice
• The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy · 2021
  No notice
• The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation · 2021
  No notice
• Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high‐risk human papillomavirus cervical carcinomas · 2020
  Not checked
• Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women · 2020
  Not checked
• MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21cip1 · 2020
  Not checked
• The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer · 2020
  No notice
• Biological and clinical aspects of HPV-related cancers · 2020
  No notice
• Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy · 2020
  No notice
• Human Papilloma Virus-Associated Cervical Cancer and Health Disparities · 2019
  No notice
• Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers · 2019
  No notice
• LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells · 2019
  Not checked
• Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation · 2019
  Not checked
• Tumor diversity and the trade-off between universal cancer tasks · 2019
  Not checked
• Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1 · 2019
  No notice

and 10 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.